Avista Healthcare

Transaction supports healthcare industry shift to more convenient, cost-effective care settings; provides technology-driven connection between pharmacies, diagnostic providers, and payors San Diego, Calif. – December 14, 2021 – XIFIN today announced the strategic acquisition of OmniSYS, a leading provider of technology solutions for the retail pharmacy industry. Building on the acquisition of Computerized Management Services in July 2021, this transaction […]

NEW YORK, Dec. 13, 2021 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced that it has become a signatory to the United Nations-supported Principles for Responsible Investment (PRI), joining the leading international network of institutional investors committed to developing a more sustainable global financial system. The Principles for Responsible […]

Kortrijk (Belgium), 26 November 2021 About the Acquisition Vision Healthcare reached an agreement with the shareholder of Vitamaze GmbH for the acquisition of 100% of the shares in Vitamaze GmbH (“Vitamaze” or the “Company”), a leading European e-commerce player active in the vitamins and nutritional supplements markets mainly through Amazon across Europe and e-pharma. Vitamaze […]

Paris, France, November 8, 2021 — Cooper Consumer Health (“Cooper”) a leading European independent over-the-counter drug manufacturer and distributor, is pleased to announce the appointment of Bart Meermans as its new Chief Executive Officer and the agreement to acquire French consumer health food supplement business, Lashilé Beauty. Bart Meermans has a wealth of industry experience […]

— Ownership period defined by Acino’s transformation and growth to become leading provider of trusted and innovative pharmaceuticals in emerging markets — New York, NY and Zurich, September 16, 2021 — Leading healthcare investors Avista Capital Partners (“Avista Capital”) and Nordic Capital (through Nordic Capital CV1) today announced that they have entered into a definitive […]

NEW YORK, Sept. 10, 2021 — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced the completion of its sale of Arcadia Consumer Healthcare, Inc. (“Arcadia”), a recognized leader in the consumer healthcare market for over-the-counter (“OTC”) medicines and premium vitamins and nutritional supplements, to Bansk Group. The transaction was first announced […]

— Divestiture advances Company’s transformation and emphasis on eye care and ocular aesthetics — — Proceeds of the sale will be used to retire a substantial portion of outstanding debt — BRIDGEWATER, N.J., Aug. 30, 2021 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical company, today announced that […]

Thompson Dean to Transition to Chairman; David Burgstahler to Become Sole Managing Partner Josh Tamaroff and Alex Yu named Partners as Avista continues to realize significant growth NEW YORK, Aug. 18, 2021 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced that effective December 31, 2021,Tom Dean will transition from Co-Managing […]

NEW YORK, Aug. 12, 2021 /PRNewswire/ — Avista Public Acquisition Corp. II (the “Company”), a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses, announced today the pricing of its initial public offering of 23,000,000 units, which includes 3,000,000 units issued upon the exercise of the underwriters’ overallotment option, […]

NEW YORK, Aug. 9, 2021 /PRNewswire/ — Avista Public Acquisition Corp. II (the “Company”), a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses, announced today the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit.  The units will be listed on the […]

NEW YORK, Aug. 9, 2021 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, announced that it has entered into a definitive agreement to sell Arcadia Consumer Healthcare, Inc. (“Arcadia”), a recognized leader in the consumer healthcare market for over-the-counter (“OTC”) medicines and premium vitamins and nutritional supplements, to Bansk Group, […]

Osmotica will receive a $110 million upfront cash payment, with the potential to receive up to $60 million in additional milestone payments Alora will acquire manufacturing operations in Marietta, Georgia in addition to legacy products Osmotica will retain the RVL Pharmaceuticals business focused on ophthalmology and aesthetics, led by its flagship product, UPNEEQ® Osmotica will […]